PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+17.73%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.02B
AUM Growth
+$3.02B
(+15%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
52.68%
Holding
169
New
33
Increased
35
Reduced
22
Closed
35
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$54M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$39.6M |
| 3 |
Merit Medical Systems
MMSI
|
$33.4M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$30.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
$27.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$58.2M |
| 2 |
NXTM
NxStage Medical Inc.
NXTM
|
$34.9M |
| 3 |
AnaptysBio
ANAB
|
$22.8M |
| 4 |
Puma Biotechnology
PBYI
|
$21.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$21.5M |
Sector Composition
| 1 | Healthcare | 97.13% |
| 2 | Consumer Discretionary | 0.06% |
| 3 | Technology | 0.05% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Akebia Therapeutics
AKBA
$827M
| $29.6M | 0.98% |
1,987,400
+357,400
| +22% | +$5.31M |
|
27
Xencor
XNCR
$594M
| $28.8M | 0.95% |
1,313,095
+20,000
| +2% | +$438K |
|
28
Intuitive Surgical
ISRG
$158B
| $25.8M | 0.85% |
70,585
+45,390
| +180% | -$1.82M |
|
|
CBAY
29
DELISTED
Cymabay Therapeutics
CBAY
| $24.7M | 0.82% |
2,685,882
+335,000
| +14% | +$3.08M |
|
|
BOLD
30
DELISTED
Audentes Therapeutics, Inc
BOLD
| $24.4M | 0.81% |
781,309
| – | – |
|
31
Assembly Biosciences
ASMB
$183M
| $24.3M | 0.8% |
536,626
+94,793
| +21% | +$4.29M |
|
32
Zimmer Biomet
ZBH
$20.8B
| $24.1M | 0.8% |
+200,000
| New | +$24.1M |
|
|
DBVT
33
DBV Technologies
DBVT
$249M
| $24.1M | 0.8% |
978,619
+402,200
| +70% | +$9.89M |
|
34
iRhythm Technologies
IRTC
$5.67B
| $24M | 0.79% |
427,371
+54,700
| +15% | +$3.07M |
|
35
Wave Life Sciences
WVE
$1.27B
| $23.3M | 0.77% |
662,798
+20,000
| +3% | +$702K |
|
36
Rhythm Pharmaceuticals
RYTM
$6.75B
| $21.7M | 0.72% |
+745,135
| New | +$21.7M |
|
37
Aldeyra Therapeutics
ALDX
$350M
| $21M | 0.7% |
3,085,458
| – | – |
|
38
Vertex Pharmaceuticals
VRTX
$102B
| $20.8M | 0.69% |
138,626
| – | – |
|
39
uniQure
QURE
$954M
| $20.5M | 0.68% |
1,047,950
+7,831
| +0.8% | +$153K |
|
|
NEPT
40
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $19.8M | 0.66% |
8,374,015
+1,854,381
| +28% | +$4.37M |
|
|
AVDL
41
Avadel Pharmaceuticals
AVDL
$1.42B
| $19.6M | 0.65% |
2,391,841
+842,836
| +54% | +$6.91M |
|
42
Galapagos
GLPG
$2.06B
| $19.3M | 0.64% |
206,305
-100
| -0% | -$9.38K |
|
43
Humana
HUM
$37.5B
| $19.2M | 0.64% |
77,500
-22,500
| -23% | -$5.58M |
|
|
KDMN
44
DELISTED
Kadmon Holdings, Inc.
KDMN
| $18.8M | 0.62% |
5,185,847
| – | – |
|
|
SRRA
45
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $18.7M | 0.62% |
5,000,000
+1,344,814
| +37% | +$5.02M |
|
|
NVTA
46
DELISTED
Invitae Corporation
NVTA
| $18.2M | 0.6% |
2,004,500
+120,000
| +6% | +$1.09M |
|
47
Madrigal Pharmaceuticals
MDGL
$9.7B
| $17.3M | 0.57% |
+188,893
| New | +$17.3M |
|
|
ABEOW
48
DELISTED
Abeona Therapeutics Inc. Warrant
ABEOW
| $14.6M | 0.48% |
1,259,636
| – | – |
|
|
RVNC
49
DELISTED
Revance Therapeutics, Inc.
RVNC
| $14.3M | 0.47% |
+400,000
| New | +$14.3M |
|
50
ADMA Biologics
ADMA
$4.03B
| $12.3M | 0.41% |
3,821,102
+3,100,000
| +430% | +$9.95M |
|